0000874015-17-000016.txt : 20170118 0000874015-17-000016.hdr.sgml : 20170118 20170118183820 ACCESSION NUMBER: 0000874015-17-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170115 FILED AS OF DATE: 20170118 DATE AS OF CHANGE: 20170118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Monia Brett P CENTRAL INDEX KEY: 0001537529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 17534452 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT STREET 2: C/O ISIS PHARMACEUTICALS, INC. CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-01-15 0000874015 IONIS PHARMACEUTICALS INC IONS 0001537529 Monia Brett P C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Antisense Drug Discovery Common Stock 2017-01-15 2017-01-15 4 M 0 1415 0 A 9287 D Common Stock 2017-01-17 2017-01-17 4 S 0 553 46.29 D 8734 D Common Stock 2017-01-15 2017-01-15 4 M 0 1875 0 A 10609 D Common Stock 2017-01-17 2017-01-17 4 S 0 733 46.291 D 9876 D Common Stock 2017-01-15 2017-01-15 4 M 0 1518 0 A 11394 D Common Stock 2017-01-17 2017-01-17 4 S 0 593 46.291 D 10801 D Common Stock 2017-01-15 2017-01-15 4 M 0 1594 0 A 12395 D Common Stock 2017-01-17 2017-01-17 4 S 0 623 46.29 D 11772 D Restricted Stock Units 2017-01-15 2017-01-15 4 A 0 8000 0 A Common Stock 8000 8000 D Restricted Stock Units 2017-01-15 2017-01-15 4 M 0 1415 0 D Common Stock 1415 0 D Restricted Stock Units 2017-01-15 2017-01-15 4 M 0 1875 0 D Common Stock 1875 1875 D Restricted Stock Units 2017-01-15 2017-01-15 4 M 0 1518 0 D Common Stock 1518 3034 D Restricted Stock Units 2017-01-15 2017-01-15 4 M 0 1594 0 D Common Stock 1594 4779 D Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 30, 2013. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 30, 2013. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2014. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2014. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2015. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2015. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2016. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2016. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Grant 1/15/2017 to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017. Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. /s/B. Lynne Parshall, attorney-in-fact 2017-01-18